Complement-Based Drug Development Summit leaderboard
  • Friday, September 4, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 549

Author

Pharma Journalist 9038 posts 0 comments

ALX Oncology Announces Closing of $105 Million Series C Financing

Feb 12, 2020
ALX Oncology announced the closing of a $105 million Series C equity financing. Vivo Capital was the lead investor with other new investors including funds managed by Logos Capital,…
Read More...

Novartis’ capmatinib gets FDA priority review in METex14 mutated advanced NSCLC

Feb 12, 2020
Novartis announced that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) New Drug Application (NDA). Capmatinib is a MET inhibitor…
Read More...

Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting…

Feb 12, 2020
Cannabics Pharmaceuticals Inc. announced that it has signed a Memorandum Of Understanding with RCK Medical Cannabis to develop cannabis chemovars targeted to treat gastro intestinal…
Read More...

Conference Chair from AstraZeneca invites you to attend Pre-filled Syringes East Coast 2020

Feb 12, 2020
The 7th annual Pre-filled Syringes East Coast conference and exhibition is returning to Boston USA, in April. SMi Group are delighted to have Michael Song, Senior Manager, Dosage Form…
Read More...

Registration Opens for Pre-Filled Syringes West Coast 2021

Feb 12, 2020
SMi reports: Registration is now open for the Pre-Filled Syringes West Coast Conference, which will convene in London on 14th-15th June 2021. SMi Group are delighted to announce that…
Read More...

XTANDI (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER…

Feb 12, 2020
Astellas Pharma Inc. and Pfizer Inc. announced results of the final overall survival (OS) analysis from the Phase 3 PROSPER trial, which evaluated XTANDI (enzalutamide) plus androgen…
Read More...

Bayer and Nuvisan create new research unit in Berlin

Feb 12, 2020
Bayer AG announced that it entered into a definitive agreement to transfer a large part of its Berlin-based small molecule research unit to Nuvisan, an international service provider…
Read More...

Advaxis and Personalis Announce Research Agreement to Deploy ImmunoID NeXT Platform in the ADXS-503…

Feb 11, 2020
Advaxis, Inc. and Personalis Inc. announced a collaboration to leverage Personalis’ ImmunoID NeXT Platform in Advaxis’ ongoing Phase 1/2 ADXS-503 (HOT Lung) program evaluating ADXS-503…
Read More...

Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen

Feb 11, 2020
Ligand Pharmaceuticals Incorporated announces the signing of an agreement whereby Ligand will acquire the core assets of Icagen, Inc.’s North Carolina operations, including partnered…
Read More...

LakePharma and NJ Bio Form Strategic Alliance to Provide Streamlined Antibody-Drug Conjugate…

Feb 11, 2020
LakePharma, Inc. and NJ Biopharmaceuticals LLC  announce the formation of a strategic alliance to offer streamlined antibody-drug conjugate (ADC) development solutions for the…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
  • Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
  • FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
  • Teva Discusses Lower Medicaid Drug Prices With Trump Administration
  • Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.